Mercury Biopharmaceutical (ROCO:6932) EV-to-FCF : -110.40 (As of Apr. 08, 2025)

Mercury Biopharmaceutical EV-to-FCF Chart

Mercury Biopharmaceutical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-FCF	Get a 7-Day Free Trial				-	-41.67	-	-132.97	-

Competitive Comparison of Mercury Biopharmaceutical's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Biopharmaceutical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mercury Biopharmaceutical's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Biopharmaceutical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Mercury Biopharmaceutical's EV-to-FCF falls into.

Mercury Biopharmaceutical EV-to-FCF Calculation

Mercury Biopharmaceutical's EV-to-FCF for today is calculated as:

Mercury Biopharmaceutical's current Enterprise Value is NT$4,557.68 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mercury Biopharmaceutical's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-41.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercury Biopharmaceutical  (ROCO:6932) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Mercury Biopharmaceutical's PE Ratio (TTM) for today is calculated as:

Mercury Biopharmaceutical's share price for today is NT$11.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mercury Biopharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-0.104.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Mercury Biopharmaceutical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Mercury Biopharmaceutical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Mercury Biopharmaceutical Business Description